Skip to main content
. 2016 Aug 8;8(22):949–956. doi: 10.4254/wjh.v8.i22.949

Table 2.

Percentage of sustained virological response according to demographics and clinical characteristics

RVR1 66.5%
HCV-RNA negative at EOT 70.1%
Relapse2 7.3%
SVR 123 62.7%
Age
< 50 yr 67.4%
50-65 yr 63.1%
> 65 yr 55.3%
Previous treatment
Naive 65.7%
Relapser 73.7%
Partial responder 67.2%
Null responder 55.1%
Fibrosis (%)
F1 72.7%
F2 73.4%
F3 63.3%
F4 53.4%
F4 > 65 yr 43.8%
1

HCV-RNA negative at week 4;

2

Those who achieved EOT but had HCV-RNA positive at week 12;

3

HCV-RNA negative 12 wk after the EOT. RVR: Rapid virological response; EOT: End of treatment; SVR: Sustained virological response; HCV: Hepatitis C virus.